Company Filing History:
1 out of 2,012 
1 out of 512 
1 out of 1,210 
Years Active: 2019
Title: Yusuf Vohra: Innovator in HIV Vaccine Development
Introduction
Yusuf Vohra is a notable inventor based in New York, NY (US), recognized for his contributions to the field of human immunodeficiency virus (HIV) research. He holds a patent that focuses on innovative approaches to HIV-1 vaccination.
Latest Patents
Yusuf Vohra's most recent patent is titled "Cyclic HIV-1 Env V3 glycopeptide immunogens." This invention relates to a vaccine for HIV-1, which comprises synthetic V3 glycopeptides. The patent outlines methods for making and using these immunogens to combat HIV.
Career Highlights
Throughout his career, Yusuf Vohra has worked with prestigious institutions, including Duke University and the Sloan Kettering Institute for Cancer Research. His work has significantly advanced the understanding and potential treatment of HIV.
Collaborations
Yusuf Vohra has collaborated with esteemed colleagues such as Barton F. Haynes and Hua-Xin Liao, contributing to the collective effort in HIV research and vaccine development.
Conclusion
Yusuf Vohra's innovative work in HIV vaccine development highlights his commitment to addressing critical health challenges. His contributions continue to pave the way for advancements in medical science.